Pfizer Inc PFE

Alternate Symbol(s): N.PFE

Healthcare

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.

NYSE:PFE - Post by User

Pfizer Inc

Bullboard Posts

Post by cbnewsmon Aug 15, 2000 6:37pm

414 Views

Post# 2328185

US Election and your money

How might plans for Medicare reform, patient’s bill of rights and drug price controls affect healthcare companies’ bottom lines -- and yours? Could a Gore victory or a Bush win have any effect on your portfolio? An eight-part Special Report continues today and runs through the week on America-iNvest.com. Long-term conservative investors buy Pfizer (PFE) and Schering-Plough (SGP) and accumulate Merck (MRK). He suggested that aggressive investors buy Elan Corp. (ELN) and accumulate Bristol-Myers Squibb (BMY). https://www.america-invest.com/archives?action=content&interfaceid=1463&id=1

Bullboard Posts

Visionstate set to leverage success in the U.S. market